相关实验视频

Updated: Jan 17, 2026

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

准ILT4以提高固体瘤免疫疗法的有效性:从长椅到床边

Aiqin Gao¹, Shuyun Wang², Yuping Sun²

¹Department of Thoracic Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China.

ImmunoTargets and therapy

|September 24, 2025

概括

免疫球蛋白样转录4 (ILT4) 阻断成为克服抗癌免疫疗法的有希望的策略. 向瘤微环境中的ILT4可以增强T细胞功能并提高治疗效率.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
癌症研究癌症研究

背景情况:

免疫检查点抑制剂 (ICI) 已经彻底改变了癌症治疗,但在固体瘤中表现出有限的疗效.
免疫抑制性瘤微环境 (TME) 阻碍了ICI的有效性,需要新的治疗点.
免疫球蛋白样转录4 (ILT4) 是一种抑制分子,涉及瘤生长,转移和免疫逃避.

研究的目的:

审查了解TME中ILT4功能的最新进展.
总结关于治疗ILT4抗体的翻译研究.
突出临床数据ILT4阻断增强免疫疗法.

主要方法:

关于ILT4研究的文献综述.
对ILT4抗体的翻译研究的分析.
新出现的临床试验数据的摘要.

主要成果:

ILT4在TME内的瘤细胞和免疫细胞中表达,促进瘤的进展.
针对ILT4的治疗抗体正在开发中.
早期的临床数据表明ILT4阻断可以改善免疫治疗反应.

结论:

ILT4代表了一种新的免疫治疗标,用于克服对当前癌症治疗方法的抗性.
阻断ILT4具有组合疗法的潜力,以增强抗瘤免疫力.
需要对ILT4向剂进行进一步的临床研究.

关键词:

ILT4 ILT4 的时间.临床试验是指临床试验中的临床试验.免疫抑制是一种免疫抑制.免疫疗法免疫疗法翻译研究是翻译研究.

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...